Hormones and mammographic breast density.

Area of Science:

• Biomedical imaging
• Radiology
• Breast cancer research

Background:

• Mammographic density provides insights into the hormonal environment and heritability of breast cancer.
• Widespread mammography screening enables population studies on disease determinants and individual risk factors.
• Density reflects intrinsic hormonal effects, genetics, and pharmaceutical influences, including hormone replacement therapy (HRT).

Purpose of the Study:

• To highlight the need for more accurate mammographic density measurement methods beyond BI-RADS categories.
• To emphasize the potential of density as a biomarker for risk estimation and monitoring interventions.
• To underscore the necessity of further research into natural density changes during menopause and individual variations.

Main Methods:

• Studies are underway to measure dense tissue volume as a continuous variable.
• Analysis of existing literature on HRT and its effect on mammographic density.
• Investigating the impact of different HRT preparations (combined estrogen-progestin, estrogen alone, tibolone) on breast density.

Main Results:

• Current HRT use, particularly combined continuous estrogen-progestin, increases mammographic density.
• Increased density may potentially impact the effectiveness of mammographic screening programs.
• More accurate density measurement is crucial for personalized risk assessment and intervention monitoring.

Conclusions:

• Accurate breast density measurement can serve as a valuable adjunct for breast cancer risk estimation.
• Density monitoring can aid in evaluating the effectiveness of pharmaceutical interventions (e.g., SERMs) and lifestyle changes.
• Further research is required to understand menopausal density changes and individual differences for clinical application.